FOLD FY 2024 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$528M+32.3% YoY

Gross Profit

$475M90.0% margin

Operating Income

$25M4.7% margin

Net Income

-$56M-10.6% margin

EPS (Diluted)

$-0.18

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$37M

Stock-Based Comp.

$85M

Balance Sheet

Total Assets

$785M

Total Liabilities

$591M

Stockholders' Equity

$194M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$528M	$399M	+32.3%
Gross Profit	$475M	$362M	+31.3%
Operating Income	$25M	-$77M	+132.2%
Net Income	-$56M	-$152M	+63.0%